TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,810,840 | +263.5% | 628,900 | +324.0% | 0.06% | +850.0% |
| Q4 2020 | $2,699,000 | -1.5% | 148,324 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $2,740,000 | +0.2% | 153,580 | +0.7% | 0.01% | -33.3% |
| Q2 2020 | $2,735,000 | +226.8% | 152,540 | +176.4% | 0.01% | +80.0% |
| Q1 2020 | $837,000 | -55.2% | 55,185 | -41.7% | 0.01% | -44.4% |
| Q4 2019 | $1,868,000 | +12.6% | 94,686 | -1.8% | 0.01% | -18.2% |
| Q3 2019 | $1,659,000 | +48.4% | 96,452 | +52.7% | 0.01% | +57.1% |
| Q2 2019 | $1,118,000 | +299.3% | 63,165 | +358.8% | 0.01% | +250.0% |
| Q1 2019 | $280,000 | – | 13,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |